K Wallander, I Öfverholm, K Boye… - Journal of Internal …, 2023 - Wiley Online Library
Sarcoma subtype classification is currently mainly based upon histopathological morphology. Molecular analyses have emerged as an efficient addition to the diagnostic …
EJ Bergsma, M Elgawly, D Mancuso… - Annals of …, 2024 - journals.sagepub.com
Objective The objective was to review the pharmacology, efficacy, and safety of atezolizumab (Tecentriq) for the treatment of adult and pediatric patients aged 2 years and …
Epithelioid hemangioendothelioma: a nationwide study Epithelioid hemangioendothelioma (EHE) is an ultrarare sarcoma whose natural history and treatment is not well defined. We …
S Watanabe, T Shimoi, T Nishikawa, A Kawachi… - Scientific Reports, 2023 - nature.com
Prognostic value of hematologic indices and their association with the tumor microenvironment (TME) remain unclear in advanced soft tissue sarcoma (STS). We aimed …
M Steinmann, A Rietschin, F Pagano… - Journal of Adolescent …, 2024 - liebertpub.com
Increasing awareness of gonadotoxicity in cancer treatments and infertility risk is essential for counseling young cancer patients. While fertility preservation options are available in …
K Pal, A Awad, S Yevich, JD Kuban, AL Tam… - American Journal of …, 2024 - ajronline.org
BACKGROUND. Treatment options are limited in patients with recurrent or metastatic disease after initial treatment of soft-tissue sarcoma (STS) by surgical resection, radiation, or …
EF Nassif, EZ Keung, P Thirasastr… - Current treatment options …, 2023 - Springer
Opinion Statement Myxoid/round-cell liposarcoma (MRCL) account for 30% of liposarcomas and are the most chemo-sensitive subtype of liposarcoma. The 5-year local relapse and …
Sarcomas are rare malignancies with over 100 distinct histological subtypes. Their rarity and heterogeneity pose significant challenges to identifying effective therapies, and approved …
E Jumaniyazova, A Lokhonina, D Dzhalilova… - Cancers, 2023 - mdpi.com
Simple Summary Soft tissue sarcomas represent a large heterogeneous group of malignant neoplasms that are characterized by a poor disease outcome and being poorly studied …